duv 15 mg Pill - pink capsule/oblong, 15mm
Generic Name: duvelisib
Pill with imprint duv 15 mg is Pink, Capsule/Oblong and has been identified as Copiktra 15 mg. It is supplied by Secura Bio, Inc.
Copiktra is used in the treatment of Chronic Lymphocytic Leukemia and belongs to the drug class PI3K inhibitors. Copiktra 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for duv 15 mg
Copiktra
- Generic Name
- duvelisib
- Imprint
- duv 15 mg
- Strength
- 15 mg
- Color
- Pink
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- PI3K inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Secura Bio, Inc
- National Drug Code (NDC)
- 71779-0115
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Privigen
Privigen is used to treat primary immune deficiency conditions and idiopathic thrombocytopenic ...
More about Copiktra (duvelisib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.